Peptides for chlamydophila pneumoniae vaccine and diagnosis
CA 2449715 A1 · Owner: The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services, Centers For Disea · Inventors: Carlone, George M.; Marston, Eric L.; Sampson, Jacquelyn S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Peptides are disclosed that include SEQ ID NO:1 SEQ ID NO:2, SEQ ID NO:3, SEQ , ID NO:4 SEQ ID NO:5, and SEQ ID NO:6, or a conservative variant or mimic thereof, wherein the conservative variant or mimic specifically binds an antibody that specifically binds SEQ ID NO:1 SEQ ID NO:2, SEQ ID NO:3, SEQ ID , NO:4 SEQ ID NO:5, or SEQ ID NO:6. These peptides are of use in generating an immune response against C. pneumoniae.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 31, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 31, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 31, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.